Evidence map›Paper›PMID 32096088›Full record

ArticleHernia : the journal of hernias and abdominal wall surgery2020

Stromal vascular fraction cells as biologic coating of mesh for hernia repair.

O Guillaume, B Pérez-Köhler, B Schädl, C Keibl, N Saxenhuber, P Heimel, E Priglinger, S Wolbank, H Redl, A Petter-Puchner and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Hernia : the journal of hernias and abdominal wall surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

O Guillaume3D Printing and Biofabrication Group, Institute of Materials Science and Technology, TU Wien, Vienna, Austria. olivier.guillaume@tuwien.ac.at.
B Pérez-KöhlerDepartment of Medicine and Medical Specialties, University of Alcalá, Madrid, Spain.
B SchädlAustrian Cluster for Tissue Regeneration, Vienna, Austria.
C KeiblAustrian Cluster for Tissue Regeneration, Vienna, Austria.
N SaxenhuberAustrian Cluster for Tissue Regeneration, Vienna, Austria.
P HeimelAustrian Cluster for Tissue Regeneration, Vienna, Austria.
E PriglingerAustrian Cluster for Tissue Regeneration, Vienna, Austria.
S WolbankAustrian Cluster for Tissue Regeneration, Vienna, Austria.
H RedlAustrian Cluster for Tissue Regeneration, Vienna, Austria.
A Petter-PuchnerAustrian Cluster for Tissue Regeneration, Vienna, Austria.
R FortelnyAustrian Cluster for Tissue Regeneration, Vienna, Austria.
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology · ATMedical University of Vienna · ATWilhelminen Hospital · ATAustrian Cluster for Tissue Regeneration · ATBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESTU Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe interest in non-manipulated cells originating from adipose tissue has raised tremendously in the field of tissue engineering and regenerative medicine. The resulting stromal vascular fraction (SVF) cells have been successfully used in numerous clinical applications. The aim of this experimental work is, first to combine a macroporous synthetic mesh with SVF isolated using a mechanical disruption process, and to assess the effect of those cells on the early healing phase of hernia.

methodsHuman SVF cells combined with fibrin were used to coat commercial titanized polypropylene meshes. In vitro, viability and growth of the SVF cells were assessed using live/dead staining and scanning electron microscopy. The influence of SVF cells on abdominal wall hernia healing was conducted on immunodeficient rats, with a focus on short-term vascularization and fibrogenesis.

resultsMacroporous meshes were easily coated with SVF using a fibrin gel as temporary carrier. The in vitro experiments showed that the whole process including the isolation of human SVF cells and their coating on PP meshes did not impact on the SVF cells' viability and on their capacity to attach and to proliferate. In vivo, the SVF cells were well tolerated by the animals, and coating mesh with SVF resulted in a decrease degree of vascularity compared to control group at day 21.

conclusionsThe utilization of SVF-coated mesh influences the level of angiogenesis during the early onset of tissue healing. Further long-term animal experiments are needed to confirm that this effect correlates with a more robust mesh integration compared to non-SVF-coated mesh.

Indexed as

AnimalsBiological ProductsDisease Models, AnimalHerniorrhaphyHumansMaleRatsRats, NudeSurgical MeshBiological ProductsAbdominal herniaAdipose tissueAngiogenesisMeshStromal vascular fraction

Identifiers

PMID32096088
PMCPMC7701131
OpenAlexW3006955925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.